Literature DB >> 16310964

Under the curve: critical issues for elucidating D1 receptor function in working memory.

G V Williams1, S A Castner.   

Abstract

It has been postulated that spatial working memory operates optimally within a limited range of dopamine transmission and D1 dopamine receptor signaling in prefrontal cortex. Insufficiency in prefrontal dopamine, as in aging, and excessive transmission, as in acute stress, lead to impairments in working memory that can be ameliorated by D1 receptor agonist and antagonist treatment, respectively. Iontophoretic investigations of dopamine's influence on the cellular mechanisms of working memory have revealed that moderate D1 blockade can enhance memory fields in primate prefrontal pyramidal neurons while strong blockade abolishes them. The combined behavioral and physiological evidence indicates that there is a normal range of dopamine function in prefrontal cortex that can be described as an "inverted-U" relationship between dopamine transmission and the integrity of working memory. Both in vivo and in vitro studies have demonstrated a role for dopamine in promoting the excitability of prefrontal pyramidal cells and facilitating their N-methyl-d-aspartate inputs, while simultaneously restraining recurrent excitation and facilitating feedforward inhibition. This evidence indicates that there is a fine balance between the synergistic mechanisms of D1 modulation in working memory. Given the critical role of prefrontal function for cognition, it is not surprising that this balancing act is perturbed by both subtle genetic influences and environmental events. Further, there is evidence for an imbalance in these dopaminergic mechanisms in multiple neuropsychiatric disorders, particularly schizophrenia, and in related nonhuman primate models. Elucidating the orchestration of dopamine signaling in key nodes within prefrontal microcircuitry is therefore pivotal for understanding the influence of dopamine transmission on the dynamics of working memory. Here, we explore the hypothesis that the window of optimal dopamine signaling changes on a behavioral time-scale, dependent upon current cognitive demands and local neuronal activity as well as long-term alterations in signaling pathways and gene expression. If we look under the bell-shaped curve of prefrontal dopamine function, it is the relationship between neuromodulation and cognitive function that promises to bridge our knowledge between molecule and mind.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310964     DOI: 10.1016/j.neuroscience.2005.09.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  114 in total

1.  Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory.

Authors:  Rosie G Albarran-Zeckler; Alicia Faruzzi Brantley; Roy G Smith
Journal:  Behav Brain Res       Date:  2012-03-31       Impact factor: 3.332

Review 2.  Dopamine in motivational control: rewarding, aversive, and alerting.

Authors:  Ethan S Bromberg-Martin; Masayuki Matsumoto; Okihide Hikosaka
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

3.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

4.  Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents.

Authors:  Nicholas W Simon; Bita Moghaddam
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

5.  Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory.

Authors:  Leonardo Fazio; Giulio Pergola; Marco Papalino; Pasquale Di Carlo; Anna Monda; Barbara Gelao; Nicola Amoroso; Sabina Tangaro; Antonio Rampino; Teresa Popolizio; Alessandro Bertolino; Giuseppe Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

6.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

7.  Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

Authors:  Alessandro Bertolino; Leonardo Fazio; Annabella Di Giorgio; Giuseppe Blasi; Raffaella Romano; Paolo Taurisano; Grazia Caforio; Lorenzo Sinibaldi; Gianluca Ursini; Teresa Popolizio; Emanuele Tirotta; Audrey Papp; Bruno Dallapiccola; Emiliana Borrelli; Wolfgang Sadee
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

8.  Inverted-U shaped effects of D1 dopamine receptor stimulation in the medial preoptic nucleus on sexually motivated song in male European starlings.

Authors:  Lauren V Riters; Benjamin A Pawlisch; Cynthia A Kelm-Nelson; Sharon A Stevenson
Journal:  Eur J Neurosci       Date:  2013-11-28       Impact factor: 3.386

9.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

10.  Differential effects of environmental enrichment and isolation housing on the hormonal and neurochemical responses to stress in the prefrontal cortex of the adult rat: relationship to working and emotional memories.

Authors:  P Garrido; M De Blas; G Ronzoni; I Cordero; M Antón; E Giné; A Santos; A Del Arco; G Segovia; F Mora
Journal:  J Neural Transm (Vienna)       Date:  2012-12-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.